GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Total Assets

Oculis Holding AG (FRA:CR5) Total Assets : €133.59 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Total Assets?

Oculis Holding AG's Total Assets for the quarter that ended in Sep. 2024 was €133.59 Mil.

During the past 12 months, Oculis Holding AG's average Total Assets Growth Rate was -4.30% per year. During the past 3 years, the average Total Assets Growth Rate was 26.80% per year.

During the past 4 years, Oculis Holding AG's highest 3-Year average Total Assets Growth Rate was 26.80%. The lowest was 26.80%. And the median was 26.80%.

Total Assets is connected with ROA %. Oculis Holding AG's annualized ROA % for the quarter that ended in Sep. 2024 was -61.84%. Total Assets is also linked to Revenue through Asset Turnover. Oculis Holding AG's Asset Turnover for the quarter that ended in Sep. 2024 was 0.00.

Oculis Holding AG Total Assets Historical Data

The historical data trend for Oculis Holding AG's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Total Assets Chart

Oculis Holding AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Assets
15.16 55.77 37.55 121.26

Oculis Holding AG Quarterly Data
Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.30 121.26 102.20 144.20 133.59

Oculis Holding AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Oculis Holding AG's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=99.385+21.87
=121.26

Oculis Holding AG's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=101.275+32.309
=133.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oculis Holding AG  (FRA:CR5) Total Assets Explanation

Total Assets is connected with ROA %.

Oculis Holding AG's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-85.888/( (144.196+133.585)/ 2 )
=-85.888/138.8905
=-61.84 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Oculis Holding AG's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=0/( (144.196+133.585)/ 2 )
=0/138.8905
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Oculis Holding AG Total Assets Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Oculis Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (FRA:CR5) » Definitions » Total Assets
Comparable Companies
LXRX MGNX ICVX SPRY CHRS TERN AURA ERAS NAUT MLYS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
OCS:USA OCS:Iceland CR5:Germany
Address
Bahnhofstrasse 7, Zug, CHE, 6300
Website
https://www.oculis.com
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Oculis Holding AG Headlines

No Headlines